Resistance mechanisms and countermeasures in CLDN18.2-positive tumors: from molecular networks to clinical practice
- DOI
- 10.3389/fonc.2026.1910011
- Published
- 2026-08-26
- Container
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fonc.2026.1910011,
title = {Resistance mechanisms and countermeasures in CLDN18.2-positive tumors: from molecular networks to clinical practice},
author = {Yutao Xia and Mingfang Wang and Taosheng Huang and Kai Sun and Peng Wang},
year = {2026},
journal = {Frontiers in Oncology},
doi = {10.3389/fonc.2026.1910011},
url = {https://doi.org/10.3389/fonc.2026.1910011}
}RIS
TY - JOUR TI - Resistance mechanisms and countermeasures in CLDN18.2-positive tumors: from molecular networks to clinical practice AU - Yutao Xia AU - Mingfang Wang AU - Taosheng Huang AU - Kai Sun AU - Peng Wang PY - 2026 JO - Frontiers in Oncology DO - 10.3389/fonc.2026.1910011 UR - https://doi.org/10.3389/fonc.2026.1910011 ER -
APA
Xia, Y., Wang, M., Huang, T., Sun, K., & Wang, P. (2026). Resistance mechanisms and countermeasures in CLDN18.2-positive tumors: from molecular networks to clinical practice. Frontiers in Oncology. https://doi.org/10.3389/fonc.2026.1910011
Source records
- crossref · retrieved 2026-09-26T17:32:11.561Z